Gefitinib vs Midazolam

Gefitinib vs Midazolam: Overview

This comparison examines the pharmacological differences between Gefitinib and Midazolam.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Midazolam — 1.5-2.5 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Midazolam — C18H13ClFN3.

Molecular Weight: Gefitinib — 446.9000 g/mol; Midazolam — 325.7670 g/mol.

Type: Gefitinib — Small molecule; Midazolam — Small molecule.